MedTrace Logo

Evaluation of Tamsulosin in the Treatment of Ureteral Stones

NCT00151567 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 129

Last updated 2012-12-04

No results posted yet for this study

Summary

Ureteral stones have an important place in daily urological practice, usually causing acute episodes of ureteral colic by obstructing the urinary tract. The aim of the study is to evaluate whether repeated administration of tamsulosin, a drug routinely used in the treatment of lower urinary tract symptoms, could lower the delay of elimination of the stone in patients with pelvis ureterolithiasis.

Conditions

  • Ureterolithiasis
  • Ureteral Calculi

Interventions

DRUG

Tamsulosin

Oral tamsulosin once a day until stone elimination or the end of the follow-up (42 days)

DRUG

Placebo

Oral placebo of tamsulosin once a day until stone elimination or the end of the follow-up (42 days)

Sponsors & Collaborators

  • Ministry of Health, France

    collaborator OTHER_GOV

  • Yamanouchi

    collaborator UNKNOWN

  • Rennes University Hospital

    lead OTHER

Principal Investigators

  • Francois Guillé, MD · Rennes University Hospital

  • Eric Bellissant, MD, PhD · Rennes University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-02-28
Primary Completion
2006-12-31
Completion
2006-12-31

Countries

  • France

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00151567 on ClinicalTrials.gov